Panacea Biotec Ltd.

BSE: 531349 | NSE: PANACEABIO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE922B01023 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Panacea Biotec Panacea Biotec Ltd. | BSE 437.75 -4.15 (-0.94%) | NSE 437.90 -3.65 (-0.83%) | Trade | Add

BSE Live

Oct 31, 16:01

437.75 -4.15 (-0.94%)

Volume

AVERAGE VOLUME

5-Day

2,983

10-Day

3,455

30-Day

10,537

1,161

Prev. Close

441.90
Open Price

443.20

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Oct 31, 15:51

437.90 -3.65 (-0.83%)

Volume

AVERAGE VOLUME

5-Day

57,741

10-Day

74,177

30-Day

193,891

40,822

Prev. Close

441.55
Open Price

441.55

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Panacea Biotec (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	559.09	551.93	456.92	659.22	617.65
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	559.09	551.93	456.92	659.22	617.65
Total Operating Revenues	559.09	559.17	459.95	661.23	624.81
Other Income	20.66	25.80	51.66	10.97	9.98
Total Revenue	579.75	584.96	511.61	672.20	634.78
EXPENSES
Cost Of Materials Consumed	214.07	210.46	211.03	281.25	167.76
Purchase Of Stock-In Trade	7.60	1.80	7.26	29.93	31.26
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-22.13	17.86	34.37	-48.97	5.61
Employee Benefit Expenses	173.05	149.57	126.48	182.94	156.17
Finance Costs	3.88	3.58	4.44	180.84	185.34
Depreciation And Amortisation Expenses	34.81	36.71	39.12	43.66	45.59
Other Expenses	212.41	199.54	178.76	229.95	187.37
Total Expenses	623.69	619.52	601.47	899.60	779.11
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	-43.94	-34.56	-89.86	-227.40	-144.32
Exceptional Items	35.99	36.03	102.66	1,676.21	0.00
Profit/Loss Before Tax	-7.95	1.48	12.81	1,448.81	-144.32
Tax Expenses-Continued Operations
Current Tax	0.77	0.69	2.56	400.73	2.32
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	2.29	43.99	-29.82	-0.37
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	0.77	2.98	46.55	370.91	1.96
Profit/Loss After Tax And Before ExtraOrdinary Items	-8.72	-1.51	-33.75	1,077.90	-146.28
Profit/Loss From Continuing Operations	-8.72	-1.51	-33.75	1,077.90	-146.28
Profit/Loss For The Period	-8.72	-1.51	-33.75	1,077.90	-147.74
Minority Interest	0.35	0.33	0.51	-0.02	-0.04
Consolidated Profit/Loss After MI And Associates	-8.37	-1.17	-33.24	1,077.89	-147.70
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	-1.00	0.00	-5.00	176.00	-24.00
Diluted EPS (Rs.)	-1.00	0.00	-5.00	176.00	-24.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	0.00	0.00	0.00	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00